BK vs NDRA · P/E 17, rev $20.08B vs P/E 0.0, $2.6M cap
The Bank of New York Mellon Corporation (BK) versus ENDRA Life Sciences Inc (NDRA) — a side-by-side from cached financials, not a winner call.
The Bank of New York Mellon Corporation (BK) is a banks - diversified company listed on US.
ENDRA Life Sciences Inc (NDRA) is a diagnostics & research company listed on US.
Latest reported BK revenue for 2025-12-31 was $20.08B. Net income was $5.55B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. BK currently screens at market cap $94.14B and trailing P/E 17.0.
NDRA does not have a complete income-statement cache yet.
BK currently screens at market cap $94.14B and trailing P/E 17.0. NDRA currently screens at market cap $2.6M and trailing P/E 0.0.
Not investment advice. Open the BK and NDRA stock pages for the full models.
Not investment advice.